Bond.az White LogoBond.az Black Logo

Guggenheim reiterates Buy rating on Okta stock

Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.

Michael Brown
ByMichael Brown- Senior Editor
|
0

Guggenheim has reiterated a Buy rating and $138.00 price target on Okta (NASDAQ:OKTA) ahead of its Q1 fiscal 2027 earnings report on May 28, 2026.

The firm expects Okta to beat consensus estimates for Q1 revenue, including both subscription and total revenue. However, risks exist for Q2 revenue guidance if business momentum doesn't improve.

Okta shares currently trade at $85.70. Bond.az analysis suggests the stock is undervalued. The company maintains a strong gross profit margin of 77%. EPS forecast for fiscal 2027 is $3.96.

Guggenheim believes Okta's 9% year-over-year revenue growth guidance is achievable. The company could raise guidance by at least the amount of the Q1 beat.

Field checks showed improvement: out of five partners, two exceeded plan, two met plan, and one fell short. Pipelines were similarly split.

Federal new annual contract value contribution was about $6 million in Q1, less than 10% of total annual contract value.

Recently, several analysts including Cantor Fitzgerald, KeyBanc, Barclays, Raymond James, and BMO Capital have issued positive ratings on Okta.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
Guggenheim reiterates Buy rating on Okta stock | Bond.az